Mr. Sergio Sandoval-Alarcon | Medicine and Health Sciences PhD Student at Universidad de Valparaiso, Chile

Dr. Sergio Sandoval-Alarcón is a seasoned Chilean academic and Associate Professor at the School of Kinesiology, Faculty of Medicine, Universidad de Valparaíso. With over two decades of experience in teaching, clinical practice, and curriculum development, he has made significant contributions to the fields of clinical biomechanics, ergonomics, and anatomy education. His research emphasizes improving musculoskeletal health through ergonomic interventions, as demonstrated by his recent publication in the Q1-ranked Applied Ergonomics. Dr. Sandoval-Alarcón holds a Master’s degree in Clinical Biomechanical Assessment and numerous postgraduate diplomas in areas such as scientific research, university teaching, and manual therapy. He has pioneered educational innovations using digital platforms for anatomy instruction and has been a key figure in developing kinesiology programs across multiple Chilean universities. His dedication to health promotion, interdisciplinary collaboration, and pedagogical advancement underscores his commitment to both academic excellence and public health impact.

Professional Profile

🎓 Education

Dr. Sergio Sandoval-Alarcón has built a robust academic foundation grounded in health sciences and clinical biomechanics. He earned his Bachelor’s degree in Kinesiology with Highest Distinction in 1999 from the Universidad Católica del Maule, Chile, followed by his Master’s degree in Clinical Biomechanical Assessment in 2016 from the prestigious Instituto de Biomecánica de Valencia (IBV), Universitat Politècnica de València, Spain. To further enrich his expertise, he has completed a wide range of postgraduate diplomas and certifications in scientific research, manual therapy, university teaching, coaching, health promotion, and competency-based training. These include programs from the Universidad de Chile, Pontificia Universidad Católica de Chile, Universidad de Playa Ancha, and Universidad de Talca, among others. His diverse and continuous educational journey reflects a deep commitment to lifelong learning and academic excellence.

💼 Professional Experience

Dr. Sergio Sandoval-Alarcón brings over two decades of rich and diverse professional experience in academia, clinical practice, and health education. He currently serves as an Associate Professor at the School of Kinesiology, Faculty of Medicine, Universidad de Valparaíso, where he has been a tenured faculty member since 2006. His teaching portfolio includes key subjects such as Human Anatomy, Biomechanics, and Clinical Kinesiology, and he has also led curriculum design and innovation initiatives. Beyond the classroom, he has served as a lecturer at several Chilean universities including Universidad de Playa Ancha, Universidad Andrés Bello, and Universidad de Aconcagua. Clinically, he worked extensively in primary health care settings, specializing in musculoskeletal and cardiovascular rehabilitation. Additionally, he has held leadership roles such as Program Director of Kinesiology at Universidad del Mar and has supervised numerous clinical internships and teaching diplomas. His career demonstrates a strong commitment to integrating academic rigor with community health needs.

🔬 Research Interests

Dr. Sergio Sandoval-Alarcón’s research interests lie at the intersection of clinical biomechanics, ergonomics, and health education. He is particularly focused on the biomechanical assessment of human movement and the prevention of work-related musculoskeletal disorders, aiming to improve both clinical outcomes and workplace health. His studies often explore how ergonomic interventions can enhance physical function and reduce injury, especially in high-risk professions like dentistry. In parallel, he is deeply engaged in educational innovation, investigating digital methodologies for teaching anatomy and kinesiology, including the use of social media platforms for academic engagement. Through both applied clinical research and pedagogical development, Dr. Sandoval-Alarcón contributes to advancing health sciences in a multidisciplinary and impactful way.

🏆 Awards and Honors

While Dr. Sergio Sandoval-Alarcón’s CV does not explicitly list formal awards or honors, his professional achievements reflect significant recognition through academic promotions, leadership roles, and scholarly contributions. His appointment as a tenured Associate Professor at the Universidad de Valparaíso highlights his respected status within the academic community. Additionally, his peer-reviewed publications in high-impact journals, such as Applied Ergonomics, and his involvement in national conferences on pedagogical innovation demonstrate professional acknowledgment of his research and teaching excellence. His selection as a tutor and lecturer in multiple postgraduate programs and diplomas further signifies his standing as a trusted expert and educator in the fields of kinesiology and clinical biomechanics.

📘Publications Top Noted

Title: Impact of ergonomic interventions on musculoskeletal health and work performance in dentists and dental students: a scoping review
Authors: Sergio Sandoval-Alarcón, René Bäumle, Hugo I. Castellucci
Year: 2025

✅ Conclusion

Dr. Sergio Sandoval Alarcón is a strong and competitive candidate for the Best Review Paper Award, primarily on the strength of his 2025 scoping review in a top-tier journal and his deep expertise in clinical biomechanics and ergonomics. His academic maturity, teaching leadership, and commitment to evidence-based practice support his candidacy.

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Published on 22/04/202522/04/2025 by Research Hypothesis

Tawanda Chivese | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Tawanda Chivese, University of Washington Tacoma, United States

Assist. Prof. Dr. Tawanda Chivese is an accomplished epidemiologist specializing in clinical epidemiology. With a Ph.D. in Medicine from the University of Cape Town, and an MSc (cum laude) in Clinical Epidemiology from Stellenbosch University, Dr. Chivese has a strong foundation in advanced epidemiological methods, biostatistics, and global health. He is currently an Assistant Professor of Epidemiology at the University of Washington Tacoma, and an Extraordinary Senior Lecturer at Stellenbosch University. Over his career, Dr. Chivese has led impactful international research on diabetes, gestational diabetes, cardiometabolic diseases, and mental health outcomes. His work has been published in high-impact peer-reviewed journals, and he actively contributes as a journal reviewer and editorial board member. Dr. Chivese’s commitment to academic excellence, mentorship, and research collaboration marks him as a distinguished researcher with significant contributions to global public health.

Publication Profile

Orcid

Education

Dr. Tawanda Chivese holds a Ph.D. in Medicine (2021) from the University of Cape Town, where he investigated the long-term effects of hyperglycemia in pregnancy on offspring obesity and cardiovascular risk. He earned his MSc Clinical Epidemiology (cum laude, 2014) from Stellenbosch University, completing advanced coursework in epidemiology, biostatistics, and systematic reviews. His Master’s research focused on cigarette smoking and Crohn’s Disease phenotypes. Earlier, he completed a Bachelor of Science (Honours) in Nursing Science (2006) from the University of Zimbabwe, developing a strong clinical foundation. He has supplemented his formal education with specialized training in systematic reviews, digital skills, blended learning, biomedical ethics, and diagnostic test accuracy through global institutions like the University of Birmingham and the University of Oxford. Dr. Chivese’s comprehensive education underpins his expertise in clinical epidemiology and global health research.

Experience

Dr. Chivese is currently an Assistant Professor (tenure-track) at the University of Washington Tacoma (2024-present), leading epidemiology and public health teaching, collaborative research on gestational diabetes, and supervising student research. Previously, he served as Assistant Professor at Qatar University (2019-2024), where he coordinated key courses, redesigned epidemiology curricula, and mentored over 100 student researchers, many winning top awards. He fostered collaborations with the Qatar Ministry of Public Health and Qatar Biobank. Concurrently, Dr. Chivese has held honorary positions at Stellenbosch University and the South African Medical Research Council since 2016. His experience combines academic leadership, innovative teaching, curriculum development, large-scale collaborative research, and scholarly publication. His global impact is evidenced by partnerships across Africa, the Middle East, and the U.S., positioning him as a leading figure in global clinical epidemiology.

Awards and Honors

Dr. Tawanda Chivese’s dedication to excellence has earned him multiple accolades. He received consistent teaching excellence awards during his tenure at Qatar University and awards for supervising the best undergraduate research projects. His leadership contributions to the Public Health Association of South Africa, serving on the executive board and as Vice Chairperson for a special interest group, underline his influence in public health leadership. His scholarly work has been recognized with prestigious grants, including funding from Qatar Foundation, Welcome Trust, and SAMRC/Newton Fund. In addition, he has been selected as an editorial board member for BMC Public Health and frequently reviews for top-tier journals like The Lancet and PLOS Medicine. These honors reflect his outstanding achievements in research, teaching, mentorship, and service to the academic and public health communities.

Research Focus

Dr. Chivese’s research primarily focuses on the intersection of metabolic and mental health diseases, particularly diabetes, cardiovascular risks, and cognitive outcomes post-gestational diabetes. He specializes in clinical epidemiology, meta-analysis, and diagnostic accuracy studies. His recent projects include investigating the developmental origins of autism spectrum disorders, the role of poor glycemic control in cognitive dysfunction, and refining meta-analysis methods for improved evidence synthesis. He also leads collaborative studies on lifestyle interventions to prevent cardiometabolic diseases in high-risk populations. His work aims to uncover critical determinants of chronic disease progression and provide actionable public health interventions. Dr. Chivese’s research approach is interdisciplinary, combining clinical insight, advanced statistical methods, and global collaboration to address complex health challenges in both low- and high-income settings.

Publication Top Notes

Prevalence of unintended pregnancy in the MENA region: a systematic review and meta-analysis

Infoveillance of COVID-19 Infections in Dentistry Using Platform X: Descriptive Study

Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis

Cross-cultural adaptation: South African Gestational Diabetes Mellitus Knowledge Questionnaire

Prevalence and factors associated with falls in older adults in a Middle Eastern population: a retrospective cross-sectional study

Estimates of the prevalence of male circumcision in sub-Saharan Africa from 2010–2023—A systematic review and meta-analysis

Integrated health system intervention aimed at reducing type 2 diabetes risk in women after gestational diabetes in South Africa (IINDIAGO): a randomised controlled trial protocol

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Published on 15/03/202515/03/2025 by Research Hypothesis

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications 📄 and supervised doctoral candidates 🎓, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors 🏥. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology 🔬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes 🏥.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology 🏅 from the University Hospital of Düsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology 📖 from the University of Düsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice 🧪. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of Düsseldorf (1983). His expertise in cancer biology, virology, and molecular research 📊 has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine 🔬💊. He is currently a Senior Postdoctoral Fellow at the Institut National de la Santé et de la Recherche Médicale, University of Strasbourg, France (2018-2025) 🏥. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) 🎓, and a Postdoctoral Fellow at the University Hospital of Düsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion 🏥, and targeting cancer stem-like cells to enhance treatment efficacy 💊. He investigates the role of non-receptor tyrosine kinases in oncogenesis 🔬 and explores immune checkpoint inhibitors and their associated cutaneous adverse effects ⚕️. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

Publication Top Notes

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms

Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance

<i>hTERT</i> Epigenetics Provides New Perspectives for Diagnosis and Evidence-Based Guidance of Chemotherapy in Cancer

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Published on 16/09/202416/09/2024 by Research Hypothesis

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Dr Emmanouil Dermitzakis, Euromedica General Clinic, Greece

Dr. Emmanouil Dermitzakis appears to be a strong candidate for the Best Researcher Award based on the following criteria:

Publication profile

google scholar

Qualifications & Experience

Extensive Training and Certification: Dr. Dermitzakis has undergone comprehensive training in Internal Medicine, Psychiatry, and Neurology, with board certification in Neurology.

Diverse Clinical Experience: He has worked in various roles, including as a research fellow, neurologist in multiple settings, and medical advisor. His roles have spanned private practice, academic institutions, and specialized clinics.

Research Contributions

Clinical Trials & Studies: Dr. Dermitzakis has been involved as both a Sub-Investigator and Principal Investigator in numerous significant clinical trials, such as the ECASS 3 trial and various migraine-related studies. His research includes evaluating new treatments and methodologies for migraine and headache disorders.

Published Works: He has published numerous articles in reputable journals, covering a wide range of topics from headache management to the effects of chemotherapy on the autonomic nervous system. His work includes research on migraine treatments, including botulinum toxin and novel therapies.

Editorial and Advisory Roles

Guest Editor: He has served as a Guest Editor for a special issue on headache disorders, reflecting his expertise and leadership in the field.

Medical Advisory Roles: As a medical advisor for the Hellenic Society of Migraine and Headache Patients, Dr. Dermitzakis contributes to advancing treatment strategies and improving patient care.

Notable Publications

His research includes impactful studies such as the evaluation of onabotulinumtoxinA in chronic migraine treatment, and the effects of chemotherapy on the autonomic nervous system. These contributions have been published in high-impact journals like The Journal of Headache and Pain and BMC Neurology.

Conclusion

Dr. Dermitzakis’s combination of clinical expertise, substantial research experience, leadership in neurology and headache management, and influential publications make him a notable candidate for the Best Researcher Award. His ongoing contributions to neurology and headache research demonstrate a commitment to advancing medical knowledge and improving patient outcomes.

Publication top notes

Patients’ preferences for headache acute and preventive treatment

Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective …

Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment

Onabotulinumtoxin-A treatment in Greek patients with chronic migraine

The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer

Headache patients in the emergency department of a Greek tertiary care hospital

OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine

Open label prospective experience of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 for episodic migraine …

Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis

Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: prospective, multicenter, real‐world data from a …

Rajendra Rohokale | Medicine and Health Sciences | Best Researcher Award

Published on 29/07/202429/07/2024 by Research Hypothesis

Rajendra Rohokale | Medicine and Health Sciences | Best Researcher Award

Dr Rajendra Rohokale, University of Florida, United States

Dr. Rajendra Rohokale is a Research Scientist at the University of Florida, specializing in Synthetic Organic Chemistry, Carbohydrate Chemistry, and Glycochemistry. With a Ph.D. from Savitribai Phule Pune University, his notable projects include synthesizing complex carbohydrates for therapeutic applications and developing fully synthetic cancer vaccines. Dr. Rohokale’s work has led to significant advancements in glycoimmunology and drug delivery. An experienced researcher and reviewer for prestigious journals, he has over 360 citations on Google Scholar and holds an Orchid ID: orcid.org/0000-0001-8083-0466. 🌟🧪🔬📚

Publication profile

Orcid

Education

🎓 From 2010 to 2017, Rajendra Rohokale pursued a Ph.D. in Organic Chemistry at the Department of Chemistry, Savitribai Phule Pune University, Pune, India, under the guidance of Prof. Dilip D. Dhavale (F.A.Sc, F.N.A.Sc.). Their thesis was titled “Chiron Approach Towards the Syntheses of Amino Acids, Piperidine, Azepane, Polyhydroxylated Pyrrolizidine Alkaloids and Activation of Diazo-Ketones Using Visible Light Photoredox Catalysis and Dye.” [Name] earned their Master of Science (Organic Chemistry) (First Class) from the same university in 2009 and completed their Bachelor of Science (Chemistry) (First Class with Distinction) from New Arts, Science, and Commerce College, Ahmednagar in 2007. 📚🔬

Experience

🧪 Since August 2023, I’ve been a Research Scientist at the University of Florida, Gainesville. From January 2019 to August 2023, I was a Post-doctoral Research Associate at the same institution. My work focuses on synthesizing complex carbohydrates and their conjugates for therapeutic applications, including the development of glycosphingolipids (GSLs) and monophosphoryl lipid-A derivatives as cancer vaccine carriers. I specialize in synthetic organic and carbohydrate chemistry, creating efficient methods for synthesizing oligosaccharides and glycoconjugates. My research aims to advance cancer immunotherapy and glycoimmunology, with significant contributions to medical science. 💊🧫🔬

Presentations

He have actively participated in numerous esteemed conferences, including the Florida Heterocyclic Conference 2022 (FloHet 2022) at the University of Florida in March 2022 and the ChemPhotoChem-EJOC joint virtual symposium on Photoreact Catalysis in December 2021. He also attended FloHet 2020 at the University of Florida in March 2020. He presented a talk at the National Conference on “Bioinspired Materials in Science” at New Arts College, Pune, India, in January 2018. Additionally, He participated in the Satellite Meeting on Frontiers in the Chemistry & Biology of Oligosaccharides in January 2014 and attended various other international conferences from 2009 to 2013. 🌟🔬🌍📚

Research focus

Dr. Rajendra Rohokale’s research focuses on the synthesis and functional analysis of glycosphingolipids (GSLs) and their interactions in cell membranes. His work spans developing bifunctional GSL probes for studying GSL-interacting proteins, creating novel vaccine adjuvants, and exploring bacterial polysaccharide-based antibacterial conjugate vaccines. He also delves into advanced chemical synthesis techniques for GSLs and their derivatives, utilizing methods like diastereoselective cycloaddition and chemoenzymatic synthesis. Dr. Rohokale’s contributions significantly impact medicinal chemistry, organic chemistry, and infectious disease research. 🧪🔬💉